XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.2
COMMON STOCK AND EARNINGS PER SHARE (Tables)
6 Months Ended
Jun. 30, 2022
COMMON STOCK AND EARNINGS PER SHARE  
Schedule of computation of earnings per share

The following is a reconciliation of basic and diluted earnings per common share for each of the periods presented (in thousands, except share and per share data):

Three Months Ended

Six Months Ended

    

June 30,
2022

    

June 30,
2021

    

June 30,
2022

    

June 30,
2021

Basic and Diluted Earnings:

Net Income (Loss) Attributable to Common Stockholders, Used in Basic EPS

$

22

$

(3,724)

$

(971)

$

4,061

Add Back: Effect of Dilutive Interest Related to 2025 Notes (1)

Net Income (Loss) Attributable to Common Stockholders, Used in Diluted EPS

22

(3,724)

(971)

4,061

Basic and Diluted Shares:

Weighted Average Shares Outstanding, Basic

6,004,178

5,898,280

5,956,798

5,888,735

Common Shares Applicable to Dilutive Effect of 2025 Notes (2)

Weighted Average Shares Outstanding, Diluted

6,004,178

5,898,280

5,956,798

5,888,735

Per Share Information:

Net Income (Loss) Attributable to Common Stockholders

Basic and Diluted

$

0.00

$

(0.63)

$

(0.16)

$

0.69

(1)

As applicable, includes interest expense, amortization of discount, amortization of fees, and other changes in net income or loss that would result from the assumed conversion. For the three and six months ended June 30 2022, a total of $0.5 million and $1.1 million, respectively, was not included, as the impact of the 2025 Notes (hereinafter defined), if-converted, would be antidilutive to the net income of under $0.1 million and the net loss of $1.0 million, for the respective periods.

(2)

A total of 1.0 million shares representing the dilutive impact of the Company’s 2025 Notes (hereinafter defined), upon adoption of ASU 2020-06 effective January 1, 2022, were not included in the computation of diluted net income (loss) attributable to common stockholders for the three and six months ended June 30, 2022 because they were antidilutive to the net income of under $0.1 million and the net loss of $1.0 million, for the respective periods.